AKI603 T001-00000005
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
AKI603 is a novel small molecule inhibitor of Aurora kinase A (AurA)(IC50 = 12.3 nM). AKI603 is developed to overcome resistance mediated by BCR-ABL-T315I mutation. AKI603 exhibits strong anti-proliferative activity in leukemic cells[1][2].
CAS nr:
1432515-73-5
Purity:
98%
Molecular Weight:
409,45
SMILES:
O=[N+](C1=CC=C(NC2=NC(N3CCN(C)CC3)=CC(NC4=NNC(C)=C4)=N2)C=C1)[O-]
Formula:
C19H23N9O2
Pathway:
Chromatin/Epigenetic,Cell Cycle/Checkpoint
Target:
Aurora Kinase,Aurora Kinase
